HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Christelle de la Fouchardiere Selected Research
Christelle de la Fouchardiere Research Topics
Disease
7
Neoplasms (Cancer)
01/2023 - 07/2014
6
Colorectal Neoplasms (Colorectal Cancer)
03/2023 - 01/2016
6
Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 08/2011
3
Microsatellite Instability
03/2023 - 12/2020
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 01/2020
3
Adenocarcinoma
01/2021 - 01/2020
3
Disease Progression
01/2021 - 07/2014
3
Fatigue
01/2020 - 09/2012
2
Esophageal Neoplasms (Esophageal Cancer)
01/2022 - 12/2020
2
Neoplasm Metastasis (Metastasis)
01/2016 - 09/2012
1
Adrenocortical Carcinoma
01/2023
1
Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2023
1
Stomach Neoplasms (Stomach Cancer)
01/2021
1
Spasm (Spasms)
01/2020
1
Hyponatremia
01/2020
1
Follicular Adenocarcinoma
02/2016
1
Papillary Thyroid Cancer
02/2016
1
Hypertension (High Blood Pressure)
01/2016
1
Diarrhea
01/2016
1
Anorexia
01/2016
1
Mucositis
01/2016
1
medullary Thyroid cancer
04/2015
1
Cardiotoxicity
04/2015
1
Exanthema (Rash)
07/2014
1
Alopecia (Baldness)
07/2014
1
Pheochromocytoma
10/2013
1
Paraganglioma (Paragangliomas)
10/2013
1
Asthenia
09/2012
1
Pneumonia (Pneumonitis)
09/2012
Drug/Important Bio-Agent (IBA)
4
pembrolizumab
IBA
03/2023 - 12/2020
3
Cisplatin (Platino)
FDA Link
Generic
01/2023 - 01/2020
3
Docetaxel (Taxotere)
FDA Link
01/2022 - 01/2020
3
Fluorouracil (Carac)
FDA Link
Generic
01/2022 - 01/2020
2
Bevacizumab (Avastin)
FDA Link
03/2023 - 12/2020
2
Cetuximab (Erbitux)
FDA Link
03/2023 - 12/2020
2
lenvatinib
IBA
01/2022 - 11/2016
2
Paclitaxel (Taxol)
FDA Link
Generic
01/2021 - 12/2020
2
regorafenib
IBA
01/2016 - 01/2016
2
vandetanib (ZD6474)
IBA
04/2015 - 09/2012
1
SDM
IBA
01/2023
1
neratinib
IBA
01/2023
1
Mitotane (Lysodren)
FDA Link
01/2023
1
B7-H1 Antigen
IBA
01/2022
1
Biomarkers (Surrogate Marker)
IBA
01/2022
1
Nivolumab
IBA
01/2022
1
DNA (Deoxyribonucleic Acid)
IBA
01/2022
1
Exonucleases (3' 5' Exonuclease)
IBA
01/2022
1
Ramucirumab
IBA
01/2021
1
Immune Checkpoint Inhibitors
IBA
01/2021
1
ErbB Receptors (EGF Receptor)
IBA
01/2021
1
Irinotecan (Camptosar)
FDA Link
Generic
12/2020
1
130-nm albumin-bound paclitaxel
IBA
01/2020
1
Gemcitabine
FDA Link
01/2020
1
Hyaluronic Acid (Hyaluronan)
IBA
01/2020
1
PEGPH20
IBA
01/2020
1
Racivir
IBA
02/2016
1
prolinedithiocarbamate (PDTC)
IBA
02/2016
1
Tyrosine Kinase Inhibitors
IBA
02/2016
1
Iodine
IBA
07/2014
1
Sorafenib (BAY 43-9006)
FDA Link
07/2014
Therapy/Procedure
9
Therapeutics
01/2023 - 08/2011
7
Drug Therapy (Chemotherapy)
03/2023 - 12/2020
2
Immunotherapy
01/2022 - 01/2021